Filling information for Sofinnova Investments, Inc. as Treemap, investor disclosed 51 total holdings based on 2023-03-31 SEC fillings. A list of the exposed holdings
Product description
CUSIP | Symbol | Name | Title Of Class | Value in 1000's | Amount | |
---|---|---|---|---|---|---|
008064107 | 008064107 | Aerovate Therapeutics Inc | COM | 75812697 | 3758686 | |
00847G705 | 00847G705 | Agenus Inc | COM | 9739335 | 6407457 | |
02043Q107 | 02043Q107 | Alnylam Pharmaceuticals Inc | COM | 89743 | 448 | |
04351P101 | 04351P101 | Ascendis Pharma A/S | SPONSORED ADR | 80847311 | 754032 | |
05464T104 | 05464T104 | Axsome Therapeutics Inc | COM | 7456865 | 120896 | |
09062X103 | 09062X103 | Biogen Inc | COM | 36866778 | 132600 | |
09061G101 | 09061G101 | Biomarin Pharmaceutical Inc | COM | 34912563 | 359035 | |
097702104 | 097702104 | Bolt Biotherapeutics Inc | COM | 3828667 | 2754437 | |
12648L601 | 12648L601 | CTI Biopharma Corp | COM | 11737076 | 2794542 | |
15117B202 | 15117B202 | Celldex Therapeutics Inc | COM | 15089904 | 419397 | |
16961L106 | 16961L106 | Chinook Therapeutics Inc | COM | 23204356 | 1002348 | |
23282W605 | 23282W605 | Cytokinetics Inc | COM | 12450081 | 353796 | |
252131107 | 252131107 | Dexcom Inc | COM | 29884633 | 257227 | |
532457108 | 532457108 | Eli Lilly and Co | COM | 47082882 | 137100 | |
30161Q104 | 30161Q104 | Exelixis Inc | COM | 16134427 | 831243 | |
36118A100 | 36118A100 | Fusion Pharmaceuticals Inc | COM | 441463 | 117099 | |
36338D108 | 36338D108 | Galera Therapeutics Inc | COM | 7894303 | 3083712 | |
374163103 | 374163103 | Geron Corp | COM | 17956516 | 8274892 | |
G46188101 | G46188101 | Horizon Therapeutics PLC | SHS | 44618506 | 408819 | |
45166A102 | 45166A102 | IDEAYA Biosciences Inc | COM | 6221736 | 453149 | |
46583P102 | 46583P102 | IVERIC bio Inc | COM | 22042542 | 905982 | |
N44445109 | N44445109 | Immatics NV | SHS | 21615589 | 3132694 | |
45253H101 | 45253H101 | ImmunoGen Inc | COM | 7390203 | 1924532 | |
45720L107 | 45720L107 | Inhibrx Inc | COM | 23483489 | 1244488 | |
45790W108 | 45790W108 | Inozyme Pharma Inc | COM | 20944915 | 3655308 | |
46120E602 | 46120E602 | Intuitive Surgical Inc | COM | 38215502 | 149589 | |
48576A100 | 48576A100 | Karuna Therapeutics Inc | COM | 322070243 | 1773124 | |
492327101 | 492327101 | Keros Therapeutics Inc | COM | 3292170 | 77100 | |
50127T109 | 50127T109 | Kura Oncology Inc | COM | 7535747 | 616169 | |
56854Q200 | 56854Q200 | Marinus Pharmaceuticals Inc | COM | 8282684 | 1200389 | |
58933Y105 | 58933Y105 | Merck & Co Inc | COM | 89529526 | 841522 | |
632307104 | 632307104 | Natera Inc | COM | 172143091 | 3100560 | |
65343E108 | 65343E108 | Nextcure Inc | COM | 3954347 | 2671856 | |
G6674U108 | G6674U108 | Novocure Ltd | ORD SHS | 3007000 | 50000 | |
GB00BYWYV | GB00BYWYV | Nucana PLC | COMMON SHARES | 2304240 | 2400000 | |
67022C106 | 67022C106 | Nucana PLC | SPONSORED ADR | 5376559 | 5599999 | |
70465T107 | 70465T107 | PDS Biotechnology Corp | COM | 877205 | 142635 | |
69366J200 | 69366J200 | PTC Therapeutics Inc | COM | 25048082 | 517095 | |
74349U108 | 74349U108 | Prometheus Biosciences Inc | COM | 13290723 | 123842 | |
75615P103 | 75615P103 | Reata Pharmaceuticals Inc | CL A | 57068938 | 627683 | |
76155X100 | 76155X100 | Revolution Medicines Inc | COM | 3981931 | 183838 | |
78462F103 | 78462F103 | SPDR S&P 500 ETF Trust | TR UNIT | 81878000 | 200000 | |
803607100 | 803607100 | Sarepta Therapeutics Inc | COM | 16410729 | 119065 | |
87164F105 | 87164F105 | Syndax Pharmaceuticals Inc | COM | 22712955 | 1075424 | |
87166L100 | 87166L100 | Synlogic Inc | COM | 363382 | 574972 | |
89422G107 | 89422G107 | Travere Therapeutics Inc | COM | 28421085 | 1263721 | |
92337R101 | 92337R101 | Vera Therapeutics Inc | CL A | 26905131 | 3467156 | |
92764N102 | 92764N102 | Vir Biotechnology Inc | COM | 15301398 | 657559 | |
984241109 | 984241109 | Y-mAbs Therapeutics Inc | COM | 10993333 | 2194278 | |
98943L107 | 98943L107 | Zentalis Pharmaceuticals Inc | COM | 24751866 | 1439062 | |
09609G100 | 09609G100 | bluebird bio Inc | COM | 2139552 | 672815 |